Cheniere Announces Substantial Completion of Train 6 at the Sabine Pass Liquefaction Project
HOUSTON–(BUSINESS WIRE)–Cheniere Energy Partners, L.P. (“Cheniere Partners”) (NYSE American: CQP), a subsidiary of Cheniere Energy,…
Year: 2022
IT Product Revenue Grew 7.2% Through Top-Tier Distribution in North America in 2021, According to IDC’s North America Weekly Distribution Tracker, powered by GTDC
NEEDHAM, Mass.–(BUSINESS WIRE)–#IDCTracker–Total IT product revenue reported by members of the Global Technology Distribution Council…
Belden Ranked as a Top Five Stock on the Argent St. Louis Stock Index
Transformation and solutions focus cited as the core reasons for the positive results ST. LOUIS–(BUSINESS…
Elanco Adds New Tools to Advance U.S. Livestock Sustainability Efforts
Elanco announces UpLook™ Insights Engine for Sustainable Progress Elanco announces the creation of Athian, a…
BTIG Expands Investment Banking Group with Head of Financial Institutions Alex Alden
NEW YORK–(BUSINESS WIRE)–BTIG announced today that Alex Alden has joined the firm as a Managing…
Blackstone Secured Lending Announces Fourth Quarter and Full Year 2021 Earnings Release and Conference Call
NEW YORK–(BUSINESS WIRE)–Blackstone Secured Lending Fund (NYSE:BXSL) (the “Company”) announced today that it will host…
Crescent Energy Announces Offering of $150 Million Private Placement of Additional 7.250% Senior Notes Due 2026
HOUSTON–(BUSINESS WIRE)–$CRGY–Crescent Energy Company (NYSE: CRGY) (“we” or “our”) announced today that, subject to market…
Blackhawk Network’s Velocity B2B Expands Partnership with Kroger to Offer Mastercard® and Visa® Bulk Prepaid Cards
PLEASANTON, Calif.–(BUSINESS WIRE)–Global branded payments provider Blackhawk Network has expanded its longtime partnership with Kroger…
RumbleOn Closes Captive Consumer Financing Facility
The Facility Provides RumbleOn Customers Unprecedented Access to Company-Originated Financing, Furthering RumbleOn’s Commitment to Enhancing…
Psyence Awarded ISO Certification through the British Standards Institute for its Natural Psilocybin Production Facility
TORONTO, Feb. 07, 2022 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the…
Eliem Therapeutics Host Virtual Investor Event Featuring Opinion Leaders in Chronic Pain Research on February 16, 2022
SEATTLE and CAMBRIDGE, United Kingdom, Feb. 07, 2022 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc. (Nasdaq:…
Plus Therapeutics to Present at BIO CEO & Investor Conference
AUSTIN, Texas, Feb. 07, 2022 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
Tonix Pharmaceuticals to Participate in BIO CEO & Investor Conference
CHATHAM, N.J., Feb. 07, 2022 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix…
Orchard Therapeutics Announces Multiple Presentations at WORLDSymposium™ 2022
BOSTON and LONDON, Feb. 07, 2022 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader,…
Evelo Biosciences Announces Highly Significant Reductions in Clinically Validated Inflammatory Cytokines in EDP1815 Phase 2 Psoriasis Trial
EDP1815 led to significantly lower production of IL-6, IL-8 and TNF Data announced by Evelo…
Amicus Therapeutics Announces Presentations and Posters at the 18th Annual WORLDSymposium™ 2022
PHILADELPHIA, Feb. 07, 2022 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology…
Roivant to Report Financial Results for the Quarter Ended December 31, 2021 on Monday, February 14, 2022
Quarterly investor call and webcast scheduled for Monday, February 14 at 8:00 a.m. ET Roivant will…
Cyclacel Pharmaceuticals to Participate in 2022 BIO CEO & Investor Conference
BERKELEY HEIGHTS, N.J., Feb. 07, 2022 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ:…
Akouos Presents Nonclinical Data Demonstrating Potential Applicability of Precision Genetic Medicine Platform for a Broad Range of Inner Ear Conditions at the Association for Research in Otolaryngology 45th Annual Mid-Winter Meeting
– Data from two nonclinical studies evaluating protein expression and tolerability support future clinical development…
Cullinan Oncology to Present at SVB Leerink’s 11th Annual Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today…